Infagel (Infagel)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceInterferon alfa-2Interferon alfa-2
Similar drugsTo uncover
  • Intel®-P
    lyophilizate for injections 
    GosNII OCHB FMBA, FSUE     Russia
  • Infagel
    gel locally externally 
    VECTOR-MEDICA, CJSC     Russia
    • Dosage form: & nbspgel for local and external use
    Composition:

    Infagel® is an interferon alpha-2b recombinant derived from a genetically modified producer strain and sorbed on an aluminum hydroxide gel. The polyvinyl alcohol included in the gel provides the necessary consistency and promotes film formation upon drying on the skin.

    In 1 g of gel contains 10 000 IU of interferon alpha-2 recombinant; auxiliary substances: aluminum hydroxide - 40,45 mg; polyvinyl alcohol - from 17.5 mg; purified water - up to 1 g.

    Description:Gel-like, homogeneous mass of white or white with a grayish shade of color. It is allowed to delaminate the contents of the package, which disappears when shaken.
    ATX: & nbsp

    L.03.A.B.01   Interferon alfa

    Pharmacodynamics:The interferon alpha-2b recombinant, which is part of the gel, has a wide spectrum of antiviral activity, bacteriostatic and anti-inflammatory action, as well as antitumor and immunomodulating activity.
    Indications:

    Treatment of herpetic lesions of the skin and mucous membranes - simple and herpes zoster, recurrent herpes of the face, genitals, gingivitis,herpetic stomatitis.

    Prevention of influenza and ARVI in adults who had contact with patients with influenza and ARVI.

    Contraindications:Contraindicated in persons suffering from allergic diseases in the acute stage.
    Dosing and Administration:

    In the treatment of herpetic lesions, the gel is applied to the affected skin and mucous membranes with a thin layer 2 times a day at intervals of 12 hours and dried for 10-15 minutes to form a protective film. The duration of the course of treatment is from 3 to 5 days, until the integrity of the skin and mucous membranes have completely disappeared.

    For the prevention of influenza and SARS in periods of rising morbidity, the drug is applied to the mucosa of the nasal passages 2 times a day at intervals of 12 h during the first and third weeks of the course, in the second week they take a break.

    Side effects:The drug does not give side effects.
    Interaction:For the treatment of infectious and inflammatory and viral diseases, the drug can be used in combination therapy with antibacterial drugs, glucocorticoids, interferon inducers and antiviral drugs.
    Form release / dosage:Gel for local and external use, 10 000 IU / g.
    Packaging:

    2 g or 3 g or 5 g or 10 g glass vials, sealed with rubber stoppers and crimped aluminum caps. Each vial with the Instruction for use is placed in a cardboard box.

    By 2 g or 3 g, or 5 g, or 10 g in aluminum tubes with bushon. Each tube together with the Instruction for use is placed in a cardboard box.

    Storage conditions:

    Transport and store in accordance with the requirements of SP 3.3.2.1248-03, in a dark place at a temperature of 0 to 10 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    The drug with expired shelf life is not subject to application.

    Terms of leave from pharmacies:On prescription
    Registration number:P N000647 / 01
    Date of registration:21.05.2007
    Expiration Date:Unlimited
    The owner of the registration certificate:VECTOR-MEDICA, CJSC VECTOR-MEDICA, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp26.10.2017
    Illustrated instructions
      Instructions
      Up